Proteomics/diagnosis of chorioamnionitis and of relationships with the fetal exposome

Seminars in Fetal and Neonatal Medicine

Volumn 17, Issue 1, 2012, Pages 36-45

  Buhimschi, Irina A ^a   Buhimschi, Catalin S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Funisitis; Haptoglobin; Haptoglobin related protein; Intra amniotic infection; Neonatal sepsis; Proteomics

Indexed keywords

HAPTOGLOBIN; PROTEOME;

AMNION FLUID ANALYSIS; CHORIOAMNIONITIS; DISEASE MARKER; GENOMICS; GESTATIONAL SAC; HISTOPATHOLOGY; HUMAN; INFECTION; INFLAMMATION; PROTEOMICS; REVIEW; STANDARD; VALIDATION STUDY;

AMNIOTIC FLUID; BIOLOGICAL MARKERS; CHORIOAMNIONITIS; FEMALE; FETUS; HUMANS; INFLAMMATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROTEOMICS;

EID: 83555177233     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2011.10.002     Document Type: Review

References (70)

1. Buhimschi I.A., Buhimschi C.S. Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth. Placenta 2008, 29(Suppl. A):S95-101.
2. Methods and protocols. Methods in molecular biology 2011, Vol. 818. SELDI-TOF mass spectrometry, Humana Press. 1st edition. Clarke, H. Charlotte, McCarthy, D.L. Bankert (Eds.).
3. Redline R.W. Placental pathology and cerebral palsy. Clin Perinatol 2006, 33:503-516.
4. Gibbs R.S., Castillo M.S., Rodgers P.J. Management of acute chorioamnionitis. Am J Obstet Gynecol 1980, 136:796-803.
5. Bobitt J.R., Ledger W.J. Unrecognized amnionitis and prematurity: a preliminary report. J Reprod Med 1977, 19:8-12.
6. Nath C.A., Ananth C.V., Smulian J.C., et al. New Jersey-Placental Abruption Study Investigators. Histologic evidence of inflammation and risk of placental abruption. Am J Obstet Gynecol 2007, 197:319.e1-319.e6.
7. Buhimschi C.S., Schatz F., Krikun G., et al. Novel insights into molecular mechanisms of abruption-induced preterm birth. Expert Rev Mol Med 2010, 12:e35.
8. Han Y.W., Shen T., Chung P., Buhimschi I.A., Buhimschi C.S. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 2009, 47:38-47.
9. Tita A.T., Ramin S.M. Intraamniotic infection (chorioamnionitis) (211) 31 May 2011, Topic last updated:, Available from:. http://www.uptodateonline.com.
10. Vrachnis N., Vitoratos N., Iliodromiti Z., et al. Intrauterine inflammation and preterm delivery. Ann NY Acad Sci 2010, 1205:118-122.
11. Dammann O., Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000, 12:99-104.
12. Bejar R., Wozniak P., Allard M., et al. Antenatal origin of neurologic damage in newborn infants. I. Preterm infants. Am J Obstet Gynecol 1988, 159:357-363.
13. De Felice C., Toti P., Laurini R.N., et al. Early neonatal brain injury in histologic chorioamnionitis. J Pediatr 2001, 138:101-104.
14. Grafe M.R. The correlation of prenatal brain damage with placental pathology. Neuropathol Exp Neurol 1994, 53:407-415.
15. Smulian J.C., Shen-Schwarz S., Vintzileos A.M., et al. Clinical chorio-amnionitis and histologic placental inflammation. Obstet Gynecol 1999, 94:1000-1005.
16. Heller D.S., Rimpel L.H., Skurnick J.H. Does histologic chorioamnionitis correspond to clinical chorioamnionitis?. J Reprod Med 2008, 53:25-28.
17. Lau J., Magee F., Qiu Z., et al. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 2005, 193:708-713.
18. Jacobsson B. Infectious and inflammatory mechanisms in preterm birth and cerebral palsy. Eur J Obstet Gynecol Reprod Biol 2004, 115:159-160.
19. Wu Y.W., Croen L.A., Torres A.R., Van De Water J., Grether J.K., Hsu N.N. Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol 2009, 66:663-670.
20. Ferriero D.M. Cerebral palsy: diagnosing something that is not one thing. Curr Opin Pediatr 1999, 11:485-486.
21. Buhimschi C.S., Weiner C.P., Buhimschi I.A. Clinical proteomics: a novel diagnostic tool for the new biology of preterm labor, part I: proteomics tools. Obstet Gynecol Surv 2006, 61:481-486.
22. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250:4007-4021.
23. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077.
24. Patterson S.D., Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis 1995, 16:1791-1814.
25. Yates J.R. Mass spectrometry. From genomics to proteomics. Trends Genet 2000, 16:5-8.
26. Han X., Aslanian A., Yates J.R. Mass spectrometry for proteomics. Curr Opin Chem Biol 2008, 12:483-490.
27. Kuwata H., Yip T.T., Yip C.L., Tomita M., Hutchens T.W. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun 1998, 245:764-773.
28. Kim K., Kim Y. Preparing multiple-reaction monitoring for quantitative clinical proteomics. Expert Rev Proteomics 2009, 6:225-229.
29. Buhimschi C.S., Bhandari V., Hamar B.D., et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007, 4:e18.
30. Gravett M.G., Novy M.J., Rosenfeld R.G., et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004, 292:462-469.
31. Buhimschi I.A., Christner R., Buhimschi C.S. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005, 112:173-181.
32. Buhimschi C.S., Buhimschi I.A., Abdel-Razeq S., et al. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early onset sepsis of the premature neonate. Pediatr Res 2007, 61:318-324.
33. Buhimschi I.A., Zambrano E., Pettker C.M., et al. Using proteomic analysis of the human amniotic fluid to identify histological chorio-amnionitis. Obstet Gynecol 2008, 111:403-412.
34. Buhimschi I.A., Buhimschi C.S., Weiner C.P., et al. Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form. Clin Diagn Lab Immunol 2005, 12:837-844.
35. Gravett M.G., Thomas A., Schneider K.A., et al. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res 2007, 6:89-96.
36. Buhimschi I.A., Buhimschi C.S., Norwitz E., et al. Proteomic analysis of cervico-vaginal secretions during pregnancy. Am J Obstet Gynecol 2004, 191:S137.
37. Esplin M.S., Merrell K., Goldenberg R., et al. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol 2011, 204:391.e1-391.e8.
38. Buhimschi C.S., Bhandari V., Dulay A.T., et al. Proteomics mapping of cord blood identifies haptoglobin 'switch-on' pattern as biomarker of early-onset neonatal sepsis in preterm newborns. PLoS One 2011, 6:e26111.
39. Sampson J.E., Theve R.P., Blatman R.N., et al. Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 1997, 176:77-81.
40. Norwitz E.R., Tsen L.C., Park J.S., et al. Discriminatory proteomic biomarkers analysis identifies free hemoglobin in cerebrospinal fluid of women with severe preeclampsia. Am J Obstet Gynecol 2005, 193:957-964.
41. Buhimschi I.A., Zhao G., Funai E.R., et al. Specific urinary fragments of SERPINA-1 and ALBUMIN are proteomic biomarkers of preeclampsia. Am J Obstet Gynecol 2008, 199:551.e1-551.e16.
42. Ruetschi U., Rosen A., Karlsson G., et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res 2005, 4:2236-2242.
43. Park S.J., Yoon W.G., Song J.S., et al. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics 2006, 6:349-363.
44. Cobo T., Palacio M., Martínez-Terrón M., et al. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obstet Gynecol 2011, 205(2):126.e1-126.e8.
45. Benirschke K. Examination of the placenta. Obstet Gynecol 1961, 18:309-333.
46. Naeye R.L. Disorders of the placenta and decidua. Disorder of the placenta, fetus and neonate: diagnosis and clinical significance 1992, 118-247. Mosby, St Louis.
47. Salafia C.M., Weigl C., Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989, 73:383-389.
48. Buhimschi I.A., Zhao G., Pettker C.M., et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 2007, 196:181.e1-181.e13.
49. Buhimschi C.S., Baumbusch M.A., Dulay A.T., et al. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 2009, 175:958-975.
50. Porta M., Malats N., Vioque J., et al. Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health 2002, 56:734-738.
51. Wild C.P. Complementing the genome with an 'exposome': the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005, 14:1847-1850.
52. Buhimschi C.S., Bhandari V., Han Y.W., et al. Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis 2009, 22:235-243.
53. Stoll B.J., Hansen N.I., Sanchez P.J., et al. Early-onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics 2011, 127:817-826.
54. McCrea H.J., Ment L.R. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008, 35:777-792.
55. Dexter S.C., Pinar H., Malee M.P., Hogan J., Carpenter M.W., Vohr B.R. Outcome of very low birth weight infants with histopathologic chorioamnionitis. Obstet Gynecol 2000, 96:172-177.
56. Moscuzza F., Belcari F., Nardini V., et al. Correlation between placental histopathology and fetal/neonatal outcome: chorioamnionitis and funisitis are associated to intraventricular haemorrage and retinopathy of prematurity in preterm newborns. Gynecol Endocrinol 2011, 27:319-323.
57. Kaukola T., Herva R., Perhomaa M., et al. Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res 2006, 59:478-483.
58. Vergani P., Patanè L., Doria P., et al. Risk factors for neonatal intraventricular haemorrhage in spontaneous prematurity at 32 weeks gestation or less. Placenta 2000, 21:402-407.
59. Redline R.W., Faye-Petersen O., Heller D., Qureshi F., Savell V., Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003, 6:435-448.
60. Simmonds M., Jeffery H., Watson G., Russell P. Intraobserver and interobserver variability for the histologic diagnosis of chorioamnionitis. Am J Obstet Gynecol 2004, 190:152-155.
61. Smithies O., Connell G.E., Dixon G.H. Chromosomal rearrangements and the evolution of haptoglobin genes. Nature 1962, 196:232-236.
62. Oliviero S., Cortese R. The human haptoglobin gene promoter: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. EMBO J 1989, 8:1145-1151.
63. Sinclair K.D., Allegrucci C., Singh R., et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA 2007, 104:19351-19356.
64. Bishop M.L., Fody E.P., Schoeff L.E. Clinical chemistry: principles, procedures, correlations 2005, Lippincott Williams & Wilkins, Philadelphia.
65. Rausen A.R., Gerald P.S., Diamond L.K. Haptoglobin patterns in CB serums. Nature 1961, 191:717.
66. Peters R.P., van Agtmael M.A., Danner S.A., Savelkoul P.H., Vandenbroucke-Grauls C.M. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004, 4:751-760.
67. Scott A.N., Joseph L., Bélisle P., Behr M.A., Schwartzman K. Bayesian modeling of tuberculosis clustering from DNA fingerprint data. Stat Med 2008, 27:140-156.
68. Vermunt J.K., Magidson J. Latent class cluster analysis. Applied latent class analysis 2002, 89-106. Cambridge University Press, Cambridge. J. Hagenaars, A. McCutcheon (Eds.).
69. Quaye I.K. Haptoglobin, inflammation and disease. Trans R Trop Med Hyg 2008, 102:735-742.
70. Nielsen M.J., Moestrup S.K. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009, 114:764-771.